This inventor holds 1 USPTO granted patent. Top assignee: Verseau Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Elizabeth Culyba and Patent Innovation in Immunology.
Introduction
Elizabeth Culyba is an inventor associated with Arlington, Massachusetts, and Verseau Therapeutics, Inc. Her patent work concerns approaches to modulating myeloid-cell inflammatory phenotypes.
Latest Patents
Culyba is listed as an inventor on 1 patent: “Anti-VSIG4 Compositions and Methods for Modulating Myeloid Cell Inflammatory Phenotypes and Uses Thereof.” The patent describes compositions and methods involving VSIG4 and the modulation of inflammatory characteristics in myeloid cells.
Career Highlights
Her listed patent reflects work at the intersection of biotechnology and immunology, with a focus on potential therapeutic applications. The available information identifies Verseau Therapeutics, Inc. as her company affiliation.
Collaborations
Culyba’s named coworkers include Igor Feldman and Stephen L. Sazinsky. Their shared association with the patent connects their work to research on VSIG4 and myeloid-cell inflammatory phenotypes.
Conclusion
Elizabeth Culyba’s patent activity highlights her contribution to biotechnology research focused on immune-cell modulation and potential therapeutic uses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile